EP300 and myelodysplastic syndrome: We then examined the effects of p300 loss in other mouse models of MDS, driven by Asxl1 haploinsufficiency or an Srsf2 mutation (Srsf2P95H; ref. 3; Figure 5 and Supplemental Figure 5E).